The behaviour ofvarious C,9 and C18 steroids as substrates for crystalline preparations of cortisone reductase (EC 1.1.1.53) is described. 3a(Axial,3R)-, 3a(equatorial,3R)-and 3,B(axial,3S)-hydroxy steroid-NAD oxidoreductase activities are demonstrated. Four pairs ofthe substrates differed only in the shape ofthe A/B ringjunction, three pairs differed only in substitution at C-10, and four pairs differed only in substitution in ring D. The shape of the substrate molecule and certain substituents (e.g. 10,-methyl, 17fl-hydroxy, Sodium phosphate buffers. These were made by mixing 135mM-Na2HPO4containingdisodiumEDTA (1.35mM) and 135mM-NaH2PO4 containing disodium EDTA (1.35mM) to obtain the required pH.
The behaviour ofvarious C,9 and C18 steroids as substrates for crystalline preparations of cortisone reductase (EC 1.1.1.53) is described. 3a(Axial,3R)-, 3a(equatorial,3R)-and 3,B(axial,3S)-hydroxy steroid-NAD oxidoreductase activities are demonstrated. Four pairs ofthe substrates differed only in the shape ofthe A/B ringjunction, three pairs differed only in substitution at C-10, and four pairs differed only in substitution in ring D. The shape of the substrate molecule and certain substituents (e.g. 10,-methyl, 17fl-hydroxy, 16 -oxo or 17-oxo) altered substrate behaviour, but steroids differing considerably in shape nevertheless acted as substrates, suggesting the possibility of a large or flexible binding site. Km values varied about 10-fold, many being approx. 14O,uM. Vmax. values covered a greater range (about 200-fold) and the good substrates had high Vmax. values rather than low Km values.
Hubener et al. (1959) described cortisone reductase (EC 1.1.1.53) as a 20f-hydroxy steroid-NAD oxidoreductase, and in 1965 crystalline preparations of this enzyme were found also to have some 3ax-hydroxy steroid-NAD oxidoreductase activity (J. Jeffery, unpublished work). Kinetic evidence was obtained that the 20-hydroxy and 3-hydroxy steroid-NAD oxidoreductase activities were not independent (Gibb & Jeffery, 1971 ; cf. Gibb & Jeffery, 1972a) . The 3-hydroxy steroid-NAD oxidoreductase activity appeared not to be limited to 30c-, 3-axial or 3R-hydroxy steroid-NAD oxidoreductase activity (Gibb & Jeffery, 1972b,c) and the symmetrical non-steroid adamantanone (which can be regarded as a steroid analogue) acted as a substrate (Gibb &Jeffery, 1972a) . Reaction rates differed considerably for different substrates (Gibb & Jeffery, 1972d,e) . Detailed examinations of the reaction products, and estimations of the kinetic constants for a series of steroids differing in the region of the A/B ring junction and in ring D structure, are now described. The nature of the steroid-binding site of the enzyme is considered in the light of the substrate-structure-activity relationships. Sodium phosphate buffers. These were made by mixing 135mM-Na2HPO4containingdisodiumEDTA (1.35mM) and 135mM-NaH2PO4 containing disodium EDTA (1.35mM) to obtain the required pH.
Experimental
Incubations for kinetic experiments. Reductions were done at 25°C in cells of 1cm light-path in a model SP. 800 double-beam spectrophotometer (Pye-Unicam Instruments, Cambridge, U.K.). The reaction cell contained sodium phosphate buffer, pH7.0 (2ml), 4.05mM-NADH (0.1 ml), enzyme solution (volume depending on the amount of enzyme required) and water (to make 0.56ml together with the enzyme solution), dimethyl sulphoxide (0.02ml) and steroid substrate in dimethyl sulphoxide (0.02ml). The reference cell contained sodium phosphate buffer, pH 7.0 (2ml), 3.24mM-NADH (0.1 ml), water (0.56ml) and dimethyl sulphoxide (0.04ml). The absorbance at 340nm was recorded continuously, a pen displacement of 1 cm vertically corresponding to reaction of 4.34nmol of NADH and 1cm horizontally to 8.57s. The amount of enzyme was chosen so that for most substrates 20 % of the steroid reacted in 2-4min. The initial rate was determined by fitting (by eye) a straight line to the part of the recorder trace corresponding to the first 20 % ofthe reaction. The traces were approximately linear along this portion, apart from the initial mixing period.
Oxidations were similarly carried out, but with NAD+ (final concn. 1 mM) instead of NADH (final concn. 150tM) as above. For 5o-androstane-3fi,7fl-diol, 3fl-hydroxy-5a-androstan-16-one and 3f,-hydroxy-5S.-androstan-1 7-one as test substrates, sufficient enzyme was used for reaction at 0.2, 0.1 and 0.2% respectively of the rate of the corresponding 3a-epimers to have been easily detected.
Incubations for preparation of reaction products were carried out in a similar way to that described for kinetic experiments but by using proportionally larger volumes (up to 2.7 litres), in suitable vessels, and using portions of the reaction mixture to follow the course of reaction spectrophotometrically at 340nm. The conditions used in each case are summarized in Table 1 .
Extraction of the enzymic reaction products
The reaction products were extracted with diethyl ether, examined by t.l.c., and either transferred to tubes for micro-scale derivative formation (see below) or purified by preparative t.l.c. With the larger-scale preparations, the purified product was then crystallized from methanol-water.
Characterization of enzymic reaction products Spectra. These were recorded with the following instruments: i.r., model 237 (Perkin-Elmer Ltd., Beaconsfield, Bucks., U.K.); n.m.r., model HA-100 (Varian Corp., Palo Alto, Calif., U.S.A.); u.v., model SP. 800 (Pye-Unicam).
Thin-layer chromatography. T.l.c. plates were coated with an aqueous slurry of silica gel HF254+366 or aluminium oxide G to a nominal thickness of 250,um (analytical) or 900,um (preparative), and were dried at 23°C and activated at 80°C for about 30min. The chromatograms were developed in closed tanks at 23°C, and the solvent front was allowed to ascend 17fl-Hydroxy-5oc-oestran-3-one (100) 5a-Oestrane-3, 17-dione (50) 17fl-Hydroxy-5f-oestran-3-one (100) 17fl-Hydroxy-5oc-androstan-3-one (75) Sc-Androstane-3, 17-dione (64) 5ae, 10oc-Oestrane-3,17-dione 5#-Androstane-3, 17-dione (100) 5, 17, 5ft-Androstane-3fl, 17fl-dio1
NADH (150) NADH (150) NADH (150) NADH (150) Oxidation. Chromic acid reagent consisted of chromium trioxide (1.8g), H2SO4 (2.4ml) and water (to make 10ml). To the steroid (100-150,ug) in acetone (0.5ml) was added one drop of chromic acid reagent. The mixture was shaken and then left for 5 min at 23°C. Water (5 ml) was then added and the mixture extracted with chloroform (lOmI). The chloroform extract was washed with 0.1 M-NaOH (2ml) and then with water (2ml portions) until the washings were neutral, the extract was dried over Na2SO4 and the chloroform removed by rotary evaporation. Acetylation. The steroid (100-150,ug) was dissolved in benzene (0.5 ml), acetyl chloride (0.5 ml) was added and the mixture left for 1 h at 23°C. n-Hexane (6ml) was then added, the solution washed with water until neutral, dried over Na2SO4, and solvent removed by rotary evaporation.
The application of these methods is exemplified (Table 3) for the substrate 5,B-androstane-3,17-dione. The enzymic reaction product (ERP) contained a little residual substrate (plates 1 and 2, RF 0.69 and 0.70) together with materials oflower RF value (plates 1 and 2, RF 0.41 and 0.42; RF 0.58 and 0.59). These were ketones (plate 1) and migrated like 3oc-hydroxy5fl-androstan-17-one and 3fl-hydroxy-5/3-androstan-17-one (plates 1 and 2). They were separated by preparative t.l.c. and the eluted materials were designated ERP-1 and ERP-2 respectively. Neither of these materials was 17oc-hydroxy-5fl-androstan-3-one or 1 7,B-hydroxy-5,B-androstan-3-one (plates 4 and 5, and 7 and 8). The acetylation products of ERP-1 and ERP-2 corresponded to the acetylation products of 3a.-hydroxy-5fl-androstan-17-one and 3/3-hydroxy-5/3-androstan-17-one respectively (plates 9-12). Borohydride reduction of ERP-1 and ERP-2 gave material that behaved like 5fl-androstane-3a,17fl-diol and 5/3-androstane-3/3, 17/3-diol respectively (plates 13 and 14), and the acetylation products also correVol. 135 sponded (plates 15-18). The oxidation product of ERP-1 and of ERP-2 behaved like 5,B-androstane-3,17-dione (plates 19 and 20). Thus, ofthe compounds which might be thought to be likely enzymic reaction products from 5,B-androstane-3,17-dione and NADH, all were eliminated except 3a-hydroxy-5fl-androstan-17-one for ERP-1, and 3fl-hydroxy-5fl-androstan-17-one for ERP-2. A fortuitous resemblance, which withstood reduction, acetylation, reduction followed by acetylation, and oxidation, is extremely unlikely. The identification of ERP-1 as 3ca-hydroxy-5/3-androstan-17-one and ERP-2 as 3fl-hydroxy-5fl-androstan-17-one is therefore regarded as satisfactory. The other identifications by t.l.c. were carried out similarly.
Results

Nature of the reaction
In the presence of NADH, the enzymic reaction with 17fl-hydroxy-S5-androstan-3-one gave a product unequivocally identified by t.l.c., m.p., mixed m.p., n.m.r. and i.r. spectra as 5c-androstane-3a,17f3-diol.
The enzymic reaction products similarly obtained from 5Lo-androstane-3,16-dione and 5ao-androstane-3,17-dione were unequivocally identified by t.l.c., m.p., mixed m.p. and i.r. spectra as 3ac-hydroxy-5a-androstan-16-one and 3x-hydroxy-Sac-androstan-17-one respectively. No other products were detected. In these cases therefore the course of reaction was the reduction of the 3-oxo group to give the corresponding 3ac(axial,3R)-hydroxyl group. Consistent with this, no reaction of 5ac-androstane-3fl,17fl-diol, 3,Bhydroxy-50c-androstan-16-one or 3fl-hydroxy-5ac-androstan-17-one was detected in the presence of NAD+ and under conditions that would have allowed detection of reaction at 0.2 % (or even less) of the rate of reaction of the 3a-epimers. With the other androstane substrates, the products were examined by t.l.c. of the products themselves and also of derivatives formed from them by microscale reduction, oxidation and acetylation, the appropriate authentic compounds being used for comparison in every case. The enzymic reaction with 17/3-hydroxy-5fl-androstan-3-one in the presence of NADH gave a product shown in this way to be indistinguishable from 5fl-androstane-3a,17fl-diol. The corresponding 3fl,17fl-diol was not detected. Nevertheless, both 5f3-androstane-3ac,17fl-diol and 5,Bandrostane-3,B,177B-diol were substrates in the presence of NAD+ and the reaction product in each case was not distinguished from 17fl-hydroxy-5fl-androstan-3-one. The enzymic reaction with 5,B-androstane-3,17-dione in the presence of NADH gave two products which t.l.c. examination showed to be 3ao-hydroxy-5,B-androstan-17-one and 3,B-hydroxy-5f,-androstan-17-one. The course of reaction in these cases therefore included both 3ao(equatorial,3R) and 3P(axial,3S) activities. The reaction products from the oestrane compounds were not identified because of insufficient material and lack of authentic reference specimens.
However, the enzymic reaction product from 17fl-hydroxy-5fl-oestran-3-one behaved on t.l.c. like the chemical reduction product prepared by micro-scale NaBH4 reduction. The course of this chemical reduction is known (Kirk & Hartshorn, 1968) and the expected product is 5fl-oestrane-3a,17fl-diol. The enzymic reaction product from 17fl-hydroxy-5a-oestran-3-one was distinguished from the chemical reduction product prepared by micro-scale complete reduction of 5ac-oestrane-3,17-dione, expected to be 5cx-oestrane-3fl,17fl-diol (Kirk & Harshorn, 1968) . Thus for 17fl-hydroxy-5a-oestran-3-one and 17kl-hydroxy-5fl-oestran-3-one there was no reason to suppose that the enzymic reaction did not follow the same course as for the corresponding androstane compounds, giving the 3a-hydroxy compounds. The enzymic reaction with 5-oestrane-3,17-dione gave material which appeared as a single spot on t.l.c., stained with 2,4-dinitrophenylhydrazine and was probably a hydroxyoestranone, though there was no evidence as to whether it was 3a-hydroxy-5a-oestran-17-one. 5a,10a-Oestrane-3,17-dione gave more than one product.
Rate ofreaction
Care was taken that no precipitation of steroid occurred during the kinetic experiments. (Precipitation corresponding to a 5 bM fall in steroid concentration was easily detectable under the conditions used.) 17ft-Hydroxy-5oc-androstan-3-one was seen to come out of solution above 75bM, so measurements were limited to 25-75,tM for this substrate. For other steroids, the range 30-100lM was used. Initial rates ofreaction (v) were determined in duplicate at each of six substrate concentrations, and every such experiment was repeated to give 24 'points' for each substrate. In each case, the reciprocal of v was linearly related to the reciprocal of the substrate concentration (correlation coefficients, Table 2 ). The apparent Km (Michaelis constant) and apparent V,,X. (maximum velocity) were calculated by non-weighted regression analysis (cf. the graphical method of Lineweaver & Burk, 1934) and by the weighting procedure of Wilkinson (1961) . The ratio KmlVmax.
serves as a parameter ofefficiency of utilization ofthe substrate, and in Table 3 5,B-Androstane-3,17-dione was an extremely poor substrate (initial rate 0.0044,umol min-1mg-1 at SOMM) and kinetic constants were not obtained. No inhibition by this compound of the reaction of 17,Bhydroxyoestr-5(10)-en-3-one (1O0LM) was detected under conditions that would have allowed detection of simple competitive inhibition with K, less than 550,UM. It seems likely therefore that 5fl-androstane-3,17-dione had a high KmlVinax. not attributable solely to a low V.ax..
Discussion
Four pairs of compounds (Table 2 , compounds b and d, e and h,fand i, and c andg) differed only in the shape of the A/B ring junction. The A/B trans compound was the better substrate of each pair, though this was attributable variously to its lower Km (b and d), its higher Vmax. (c andg), or both (e and h,fand i). Compounds g and i are A/B cis in different ways, and the relation of the 3-oxo group to the rest ofthe molecule is different in these two compounds, and also differs from the 5a,10#, compounds.
The only structural difference between compounds b and e, c and f, and d and h was the presence or absence of the 10,-methyl group. The 10,-methyl compound was the less efficiently utilized ofeach pair because of its much lower Vmax. value, though this effect was mollified in two cases (fand h) by lower K.
values.
The change from a 17fl-hydroxy to a 17-oxo group was the only structural difference for the pairs ofcompounds b and c, e andf, and h and i. In each case the 17-oxo compound was utilized less efficiently. Two of these pairs (b and c, and e and f) are of the same structural type (Sa, 10, B, and it is noteworthy that for one pair (b and c) the Vmax. values were similar and the Km values different, whereas for the other pair (e andf) the reverse was the case.
Consideration of the shapes and structures of the compounds studied indicates that the enzyme does not provide a binding site like a template on which, in every case, an extended region of the substrate is uniquely bound. Reaction of the various substrates is undoubtedly closely related, and probably the simplest explanation (though not the only possible explanation) would be that the same active centre is involved. If this is the case, it must permit binding in various ways. The non-steroidal but analogous compound adamantanone was a poorer substrate (KmI V,,.. about 1300) (Gibb & Jeffery, 1972a) than the steroids described here (except, perhaps, compound i), so that, even among these poor substrates, parts of the molecule other than the A ring evidently facilitate utilization as a substrate. These facts suggest that the binding region comprises a hydrophobic pocket. However, the marked difference of behaviour ofcom- Table 3 . An example ofthe characterization ofenzymic reactionproducts by t.l.c. 5,-Androstane-3,17-dione reacted with cortisone reductase and excess of NADH (see Table 1 and the Experimental section). The enzyme reaction products (ERP) and derivatives formed from them on a micro-scale were chromatographed on silica gel (S) 17fl-Hydroxy-5fl-androstan-3-one ERP-2+ 17,-hydroxy-5f-androstan-3-one Acetylated ERP-1 Acetylated 3fl-hydroxy-5fl-androstan-17-one Acetylated 3a-hydroxy-5fl-androsian-17-one Acetylated ERP-2 Acetylated 3fl-hydroxy-5/3-androstan-17-one Acetylated 3ac-hydroxy-5fl-androstan-17-one pounds a and f, caused by the relatively slight structural difference of a 16-oxo instead of a 17-oxo group, suggests a specific interaction with a polar group in this case. Polar interactions in this region may, for example, slightly alter the alignment of the steroid on the binding site. This could explain the change mainly in the apparent Vmax. and relatively slight change in apparent Km. for compounds a andf, and e and f. On the other hand, hydrophobic interactions involving the ,B side of the molecule in the region around C-10 may also modify alignment of the 3-oxo group at the catalytic site (compare, for example, compounds b and e, c andf, and dand h). Consistent with this, an adverse effect of a 1B-methyl group was previously observed (Gibb & Jeffery, 1972d (Ariens, 1954) .
